Digman Wiklund News Today

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, THE UNITED KINGDOM, CANADA, AUSTRALIA, HONG KONG, JAPAN OR ANY...

NOT FOR DISTRIBUTION OR RELEASE, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES OF AMERICA, THE UNITED KINGDOM, AUSTRALIA, CANADA, HONG KONG OR JAPAN, OR ANY...

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, THE UNITED KINGDOM, CANADA, AUSTRALIA, HONG KONG, JAPAN OR ANY...

Reference is made to Circio Holding ASAs stock exchange announcement on 9 March 2023, in which the Company announced that it had requested Atlas Special Opportunities, LLC to subscribe and...

The EPO board of appeal moved to revoke the TG01/gemcitabine combination method of use patent in pancreatic cancer The TG01 / gemcitabine combination was...

Issuer name: Circio Holding ASA Ex. date: 4 October 2023 Type of corporate action: reverse share split Other...

The annual general meeting was held on 22 May 2023 at the Companys offices at Vollsveien 19, 1366 Lysaker. Please find minutes of the meeting attached: Targovax ASA - AGM minutes For further... | May 22, 2023

The Annual General Meeting of Targovax ASA will be held at the Companys offices at Lysaker, on 22 May 2023 at 14:00 CET. Notice of attendance Notice of attendance must be received no later than... | April 28, 2023

On 13 April 2023, the Board of Directors of Targovax ASA approved the Companys Annual Report, including the financial statements for 2022, which will be processed at the Companys annual general... | April 13, 2023

Reference is made to Targovax ASAs stock exchange announcement on 9 March 2023, in which the Company announced that it had requested Atlas Special Opportunities, LLC to subscribe and pay for the... | March 30, 2023